Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Cibenzoline

Alternative Names: cibenzoline
Latest Update: 2025-01-10
Latest Update Note: Clinical Trial Update

Product Description

Cibenzoline is a class I antiarrhythmic drug with limited class III and IV activity which can be administered orally or intravenously. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/1379150/)

Mechanisms of Action: Sodium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Belgium | Egypt | France | Portugal

Approved Indications: None

Known Adverse Events: None

Company: TOA EIYO
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cibenzoline

Countries in Clinic: Japan

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Cardiomyopathy, Hypertrophic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
jRCT2080224827

P2

Completed

Cardiomyopathy, Hypertrophic

2023-08-31

JapicCTI-194910

P2

Active

Cardiomyopathy, Hypertrophic

2021-08-31

Recent News Events

Date

Type

Title

08/01/2023

PubMed

 Impact of Left Ventricular Outflow Tract Obstruction on Coronary Physiological Assessment.

06/29/2023

PubMed

 Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline.

03/02/2023

PubMed

 Unmasking the severity of aortic stenosis by pharmacological elimination of left ventricular outflow tract obstruction: a case report.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions